Literature DB >> 7708765

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

X Zhou1, P Berglund, H Zhao, P Liljeström, M Jondal.   

Abstract

The Semliki Forest virus (SFV) expression system can be used to package recombinant RNA into infectious suicide particles. Such RNA encodes only the SFV replicase and the heterologous protein but no structural proteins of SFV, and it is thus deficient in productive replication. We demonstrate here that infection of C57BL/6 (H-2b) and BALB/c (H-2d) mice with recombinant SFV expressing the nucleoprotein (NP) of influenza virus (SFV-NP) resulted in efficient priming of influenza virus-specific CD8+ cytotoxic T-cell (CTL) responses. The generated CTLs lysed both homologous (A/PR/8/34) and heterologous (A/HK/68) influenza virus-infected, or peptide-coated, target cells to a similar degree as CTLs induced by wild-type influenza virus in a major histocompatibility complex class I-restricted fashion. As few as 100 infectious units of virus induced a strong CTL response. Induction of CTL by SFV-NP could also be achieved in CD4 gene-targeted mice, demonstrating the independence of the primary CTL response of CD4+ helper T cells. One immunization generated a CTL response that peaked after 1 week, and an additional booster injection generated a CTL memory, which was still detectable after 40 days. SFV-NP immunizations also generated high-titered IgG humoral responses that remained significant after several months. These results demonstrate that the recombinant SFV suicide system is highly efficient in antigen presentation and suggest that it may have a potential as a recombinant vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708765      PMCID: PMC42348          DOI: 10.1073/pnas.92.7.3009

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Follicular dendritic cells as accessory cells.

Authors:  J G Tew; M H Kosco; G F Burton; A K Szakal
Journal:  Immunol Rev       Date:  1990-10       Impact factor: 12.988

2.  Recombination between Sindbis virus RNAs.

Authors:  B G Weiss; S Schlesinger
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

Authors:  O Rötzschke; K Falk; K Deres; H Schild; M Norda; J Metzger; G Jung; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

4.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

Authors:  W M Kast; L Roux; J Curren; H J Blom; A C Voordouw; R H Meloen; D Kolakofsky; C J Melief
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.

Authors:  H Schild; K Deres; K H Wiesmüller; G Jung; H G Rammensee
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

6.  Peptide-induced antiviral protection by cytotoxic T cells.

Authors:  M Schulz; R M Zinkernagel; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 7.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

8.  CD8 is needed for development of cytotoxic T cells but not helper T cells.

Authors:  W P Fung-Leung; M W Schilham; A Rahemtulla; T M Kündig; M Vollenweider; J Potter; W van Ewijk; T W Mak
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

9.  Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.

Authors:  A Rahemtulla; W P Fung-Leung; M W Schilham; T M Kündig; S R Sambhara; A Narendran; A Arabian; A Wakeham; C J Paige; R M Zinkernagel
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

10.  Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.

Authors:  P Aichele; H Hengartner; R M Zinkernagel; M Schulz
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  26 in total

1.  Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.

Authors:  J P Gardner; I Frolov; S Perri; Y Ji; M L MacKichan; J zur Megede; M Chen; B A Belli; D A Driver; S Sherrill; C E Greer; G R Otten; S W Barnett; M A Liu; T W Dubensky; J M Polo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.

Authors:  M Tsuji; C C Bergmann; Y Takita-Sonoda; K Murata; E G Rodrigues; R S Nussenzweig; F Zavala
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 4.  Alphavirus-based expression vectors: strategies and applications.

Authors:  I Frolov; T A Hoffman; B M Prágai; S A Dryga; H V Huang; S Schlesinger; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.

Authors:  Francesca Avogadri; Roberta Zappasodi; Arvin Yang; Sadna Budhu; Nicole Malandro; Daniel Hirschhorn-Cymerman; Shakuntala Tiwari; Maureen F Maughan; Robert Olmsted; Jedd D Wolchok; Taha Merghoub
Journal:  Cancer Immunol Res       Date:  2014-02-26       Impact factor: 11.151

7.  Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.

Authors:  Francesca Avogadri; Taha Merghoub; Maureen F Maughan; Daniel Hirschhorn-Cymerman; John Morris; Erika Ritter; Robert Olmsted; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

Review 8.  Manipulation of the Semliki Forest virus genome and its potential for vaccine construction.

Authors:  G J Atkins; B J Sheahan; P Liljeström
Journal:  Mol Biotechnol       Date:  1996-02       Impact factor: 2.695

9.  Viral alteration of cellular translational machinery increases defective ribosomal products.

Authors:  Peter Berglund; Diana Finzi; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.

Authors:  S P Mossman; F Bex; P Berglund; J Arthos; S P O'Neil; D Riley; D H Maul; C Bruck; P Momin; A Burny; P N Fultz; J I Mullins; P Liljeström; E A Hoover
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.